TY - CHAP PY - 2008 DA - 2008// BT - Diagnosis and management of ADHD in children, young people and adults: NICE Clinical Guideline 72 ID - ref1 ER - TY - JOUR AU - Polanczyk, G. AU - De Lima, M. AU - Lessa Horta, B. AU - Biederman, J. AU - Rohde, A. u. g. u. s. t. o. L. u. i. s. PY - 2007 DA - 2007// TI - The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis JO - Am J Psychiatry VL - 164 UR - https://doi.org/10.1176/appi.ajp.164.6.942 DO - 10.1176/appi.ajp.164.6.942 ID - Polanczyk2007 ER - TY - CHAP PY - 2006 DA - 2006// TI - Methylphenidate, atomoxetine and dexamfetamine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents BT - Review of Technology Appraisal 13 Technology Appraisal 98 ID - ref3 ER - TY - JOUR AU - McCarthy, S. AU - Asherson, P. AU - Coghill, D. AU - Hollis, C. AU - Murray, M. AU - Potts, L. AU - Sayal, K. AU - De Soysa, R. AU - Taylor, E. AU - Williams, T. AU - Wong, I. C. K. PY - 2009 DA - 2009// TI - Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults JO - British J Psych VL - 194 UR - https://doi.org/10.1192/bjp.bp.107.045245 DO - 10.1192/bjp.bp.107.045245 ID - McCarthy2009 ER - TY - CHAP PY - 2009 DA - 2009// BT - Notice to Applicants. A Guideline on Summary of Product Characteristics (SmPC) ID - ref5 ER - TY - CHAP PY - 2007 DA - 2007// BT - Committee for medicinal products for human use (CHMP). Guideline on conduct of pharmacovigilance for medicines used by the paediatric population ID - ref6 ER - TY - CHAP PY - 2005 DA - 2005// BT - Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CBER). Guidance for Industry Development and Use of Risk Minimization Action Plans ID - ref7 ER - TY - CHAP AU - Savill, N. AU - Bushe, C. PY - 2008 DA - 2008// TI - A systematic review of the contra-indications in the Summary of Product Characteristics for drugs licensed for ADHD in the UK BT - Poster presentation at the 16th European Congress of Psychiatry, Nice, France ID - Savill2008 ER - TY - CHAP PY - 2009 DA - 2009// BT - European Medicines Agency makes recommendations for safer use of Ritalin and other methylphenidate-containing medicines in the EU ID - ref9 ER - TY - CHAP PY - 2009 DA - 2009// BT - Elements recommended for inclusion in Summaries of Product Characteristics for methylphenidate-containing medicinal products authorised for the treatment of ADHD in children aged six years and above and adolescents ID - ref10 ER - TY - CHAP PY - 2009 DA - 2009// TI - Management of attention deficit and hyperkinetic disorders in children and young people BT - A national clinical guideline (number 112) ID - ref11 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/14482/SPC/Strattera++10mg%2c+18mg%2c+25mg%2c+40mg%2c+60mg+or+80mg+hard+capsules./accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/14482/SPC/Strattera++10mg%2c+18mg%2c+25mg%2c+40mg%2c+60mg+or+80mg+hard+capsules./ ID - ref12 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/8382/SPC/Concerta+XL+18+mg+-+36+mg+prolonged+release+tablets/accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/8382/SPC/Concerta+XL+18+mg+-+36+mg+prolonged+release+tablets/ ID - ref13 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/19549/SPC/Concerta+XL+27+mg+prolonged-release+tablets/accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/19549/SPC/Concerta+XL+27+mg+prolonged-release+tablets/ ID - ref14 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/19510/SPC/Medikinet+XL/accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/19510/SPC/Medikinet+XL/ ID - ref15 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/1316/SPC/Ritalin/accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/1316/SPC/Ritalin/ ID - ref16 ER - TY - STD TI - electronic Medicines Compendium: [http://www.medicines.org.uk/EMC/medicine/19664/SPC/Medikinet+Tablets/accessed 30th November 2011] UR - http://www.medicines.org.uk/EMC/medicine/19664/SPC/Medikinet+Tablets/ ID - ref17 ER - TY - STD TI - Dexamfetamine Sulphate 5 mg Tablets, Summary of Product Characteristics, March 2010 Auden Mackenzie. ID - ref18 ER - TY - STD TI - BNFC.org. British National Formulary for Children 2010-2011. ID - ref19 ER - TY - JOUR AU - Nutt, D. J. AU - Fone, K. AU - Asherson, P. AU - Bramble, D. AU - Hill, P. AU - Matthews, K. AU - Morris, K. A. AU - Santosh, P. AU - Sonuga-Barke, E. AU - Taylor, E. AU - Weiss, M. AU - Young, S. PY - 2007 DA - 2007// TI - Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology JO - J Psychopharmacol VL - 21 UR - https://doi.org/10.1177/0269881106073219 DO - 10.1177/0269881106073219 ID - Nutt2007 ER - TY - STD TI - Department of Health and Human Services Food and Drug Administration: Public Law 110-85. Title V--Best Pharmaceuticals for Children Act of 2007, Food and Drug Administration Amendments Act of 2007. [http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_public_laws&docid=f:publ085.110.pdf] UR - http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_public_laws&docid=f:publ085.110.pdf ID - ref21 ER - TY - STD TI - Regulation (EC) No 1901/of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. ID - ref22 ER - TY - CHAP PY - 2010 DA - 2010// TI - European network of paediatric research BT - Recognition criteria for self assessment ID - ref23 ER - TY - JOUR AU - Bangs, M. AU - Sitra, T. a. u. s. c. h. e. r. -. W. i. s. n. i. e. w. s. k. i. AU - Polzer, J. AU - Zhang Shuyu, D. V. M. AU - Acharya, N. AU - Desaiah, D. AU - Allen, A. J. PY - 2008 DA - 2008// TI - Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine JO - J Am Acad Child Adolesc Psychiatry VL - 47 UR - https://doi.org/10.1097/chi.0b013e31815d88b2 DO - 10.1097/chi.0b013e31815d88b2 ID - Bangs2008 ER - TY - JOUR AU - Waxmonski, J. G. AU - Waschbusch, D. A. AU - Pelham, W. E. AU - Draganac-Cardona, L. AU - Rotella, B. AU - Ryan, L. PY - 2010 DA - 2010// TI - Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder JO - J Clin Psychiatry VL - 71 UR - https://doi.org/10.4088/JCP.09m05496pur DO - 10.4088/JCP.09m05496pur ID - Waxmonski2010 ER - TY - JOUR AU - Martenyi, F. AU - Treuer, T. AU - Gau, S. S. AU - Hong, S. D. AU - Palaczky, M. AU - Sˇuba, J. AU - Tiberiu, M. AU - Uhlıkova, P. AU - Xu, T. AU - Zoroglu, S. AU - Gadow, K. D. AU - Walton, R. AU - Harrison, G. PY - 2009 DA - 2009// TI - Attention-deficit/hyperactivity disorder diagnosis, co-morbidities, treatment patterns, and quality of life in a pediatric population in central and eastern Europe and Asia JO - J Child Adolescent Psychopharmacol VL - 19 UR - https://doi.org/10.1089/cap.2008.0148 DO - 10.1089/cap.2008.0148 ID - Martenyi2009 ER - TY - JOUR AU - Saylor, K. AU - Williams, D. W. AU - Schuh, K. J. AU - Wietecha, L. AU - Greenbaum, M. PY - 2010 DA - 2010// TI - Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.493747 DO - 10.1185/03007995.2010.493747 ID - Saylor2010 ER -